[EN] PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS<br/>[FR] DÉRIVÉS DE PIPÉRIDIN-4-YL AZÉTIDINE EN TANT QU'INHIBITEURS DE JAK1
申请人:INCYTE CORP
公开号:WO2011112662A1
公开(公告)日:2011-09-15
The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
本发明提供了哌啶-4-基氮杂环衍生物及其组合物和使用方法,其调节Janus激酶1(JAK1)的活性,并且对于治疗与JAK1活性相关的疾病具有用处,例如炎症性疾病,自身免疫性疾病,癌症和其他疾病。